StockData
Ultragenyx Pharmaceutical Inc. logo

Ultragenyx Pharmaceutical Inc. (RARE) stock

RARENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 9/30
$17.73+1.03 (+6.17%)

Close on Nov 18, 2026Market cap $1.75BP/E –Yield –

Ultragenyx Pharmaceutical price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Ultragenyx Pharmaceutical's price to book ratio was 232.1× on Jan 30, 2026, against 11.5× a year earlier. Over the last 5 years it ranged from 4.1× to 335.1×, with a median of 11.8×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Jan 30, 2026232.1×+10.3
2025Dec 31, 2025221.8×+210.6
2024Dec 31, 202411.2×−97.6
2023Dec 29, 2023108.8×+101.9
2022Dec 30, 20226.9×+0.8
2021Dec 31, 20216.1×−6.5
2020Dec 31, 202012.6×+9.2
2019Dec 31, 20193.4×+0.1
2018Dec 31, 20183.3×−2.1
2017Dec 29, 20175.4×−0.8
2016Dec 30, 20166.2×−1.4
2015Dec 31, 20157.6×+0.5
2014Dec 31, 20147.0×–

More Ultragenyx Pharmaceutical figures

See a number that looks wrong?